Ratio of metastatic to examined lymph nodes, a helpful staging system and independent prognostic factor of esophagogastric junction cancer. [PDF]
PLoS ONE, 2013 BACKGROUND: The incidence of the esophagogastric junction cancer is growing rapidly. The purpose of this study is to clarify the outcome of the ratio between metastatic and examined lymph nodes in esophagogastric junction cancer patients with or without ...
Hao Zhang +6 more
doaj +1 more source
Diagnostic Approach for Esophagogastric Junction Outflow Obstruction
The Korean Journal of Gastroenterology, 2020 Esophageal manometry is the gold standard test for diagnosing primary esophageal motility disorder. With the various metrics of the high-resolution esophageal manometry, the Chicago classification provides a standard approach for the manometric diagnosis
Yu Kyung Cho
doaj +1 more source
Surgical Case Reports, 2020 Background Patients with esophagogastric junction cancer are increasing in Western and Eastern countries. Conversely, the clinical significance of surgical resection remains controversial in these patients.
Takako Tanaka +15 more
doaj +1 more source
Carcinoma of The Esophagogastric Junction
Ca-A Cancer Journal for Clinicians, 1960 G. V. Brindley, G. V. Brindley
exaly +2 more sources
Hybrid Peroral Endoscopic Myotomy for Achalasia with Prior Treatment Failure [PDF]
Clinical Endoscopy, 2021 Achalasia is a neurodegenerative motility disorder caused by enteric neuron damage in the lower esophageal sphincter. Peroral endoscopic myotomy (POEM) is a standard treatment method for achalasia.
In Kyung Yoo +2 more
doaj +1 more source
The esophagogastric junctional adenocarcinoma an increasing disease [PDF]
, 2017 Identifying and defining the esophagogastric junctional adenocarcinoma (EGJA) as an independent disease apart from gastric cancer (GC) and esophagus cancer (EG) it has always been a difficult issue entailing doubts about the appropriate therapeutic ...
Andreetti, Claudio +3 more
core +1 more source
Insights into the endoscopic management of esophageal achalasia
Therapeutic Advances in Gastrointestinal Endoscopy, 2021 Achalasia is a primary esophageal motility disorder characterized by the loss of inhibitory neurons in the myenteric plexus, resulting in impaired relaxation of the esophagogastric junction. Achalasia is an incurable disease, and the treatment modalities
Elizabeth Brindise +2 more
doaj +1 more source
Factors related to lymph node metastasis in Siewert type Ⅲ carcinoma of esophagogastric junction
Di-san junyi daxue xuebao, 2019 Objective To investigate the influencing factors for lymph node metastasis in Siewert type Ⅲ carcinoma of esophagogastric junction. Methods A total of 162 patients with Siewert type Ⅲ carcinoma of esophagogastric junction undergoing radical surgery in ...
SHEN Yonghua +3 more
doaj +1 more source
Archives of Medical Science, 2021 Introduction Gastric cancer remains the fourth leading cause of cancer-related death in Europe, while the proportion of adenocarcinomas of the esophagogastric junction has risen by more than one third over recent years.
Dimitrios Raptis +13 more
doaj +1 more source
Prospective, open, multi-centre phase I/II trial to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and oxaliplatin in patients with adenocarcinoma of the oesophagogastric junction [PDF]
, 2013 Background: This phase I/II-trial assessed the dose-limiting toxicities (DLT) and maximum tolerated dose (MTD) of neoadjuvant radiochemotherapy (RCT) with docetaxel and oxaliplatin in patients with locally advanced adenocarcinoma of the oesophagogastric ...
Arnold, Dirk +12 more
core +1 more source